CD79A and plasma cell myeloma: 44 patients were diagnosed with IgG-type myeloma (45.8%), 29 with light-chain-type myeloma (30.2%), 21 with IgA-type myeloma (21.9%), and 2 with nonsecretory-type myeloma (2.1%).